Deep Track Biotech acquires 2,666,666 shares for $39,999,990.00 at $15.00; derivative conversion underway
Deep Track Biotechnology Master Fund, Ltd., a 10% owner, executed 2 separate purchases totaling 2,666,666 shares for $39,999,990.00 at $15.00 per share on 2025-09-12, the day of LBRX's recent listing (4 trading days prior to filing). This is a material capital commitment by a significant shareholder in a newly public company at its IPO reference price. The transaction is marked as a derivative-conversion event, meaning the insider's full position includes unreported derivative holdings in Form 4 Table II; the 666,666 shares showing post-transaction reflect only the converted equity portion, not the complete economic position. The cluster pattern shows 3 other insiders also acquired shares within the past 14 days, indicating broad insider appetite at current levels. Investors should monitor derivative position disclosures and track whether this cluster of acquisitions continues as LBRX trades post-listing.